Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes

Background: Little is known about pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency (PDE-ALDH7A1) in adulthood, as the genetic basis of the disorder has only been elucidated 15 years ago. This creates a knowledge gap for physicians, pediatric patients and their parents, which was aimed to address in this study using clinical data as well as patient-reported outcome measures (PROMs) for the patient's perspective. Methods: Dutch, genetically confirmed PDE-ALDH7A1 patients ≥18 years were eligible for inclusion. Clinical data were collected as well as PROMs (... Mehr ...

Verfasser: L.A. Tseng
L. Teela
M.C. Janssen
L.A. Bok
M.A.A.P. Willemsen
R.F. Neuteboom
L. Haverman
S.M. Gospe, Jr
C.R. Coughlin, 2nd
C.D.M. van Karnebeek
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Molecular Genetics and Metabolism Reports, Vol 31, Iss , Pp 100853- (2022)
Verlag/Hrsg.: Elsevier
Schlagwörter: PDE-ALDH7A1 / Adults / Patient-reported outcomes / PROMIS / Medicine (General) / R5-920 / Biology (General) / QH301-705.5
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26627410
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1016/j.ymgmr.2022.100853